Shubhra Singh, Additional Chief Secretary, Medical & Health and Family Welfare Department, Govt of Rajasthan said that Rajasthan government is dedicated towards 'swasthya' with 7.4% of public spend on healthcare.

While applauding FICCI for taking up the important topic of cancer, she shared that Rajasthan has been committed to early detection of cancer along with timely cure. “Under the Mukhyamantri Aayushman Aarogya (MAA) Yojna, there are various packages which offer relief including cashless transactions to the people covered under the scheme,” she added.

Addressing the ‘FICCI Roundtable for Rajasthan’, held under the aegis of Ministry of Health & Family Welfare, GoI, on the ‘Road Map for Making Cancer Care Affordable and Accessible in India’, Shubhra said that the state government is working on developing population-based cancer registry.

“115 hospitals are already registered in the state for cancer registry. The State Cancer Institute Jaipur is the apex cancer institute in the state, and we also have Territory cancer care centre at Bikaner and Jhalwar,” she noted.

Raj Gore, Co-lead, FICCI Task Force on Cancer Care and CEO, Healthcare Global Enterprises Limited (HCG) expressed that "Today, we are confronted with a significant challenge of increasing burden of cancer in our country. According to the FICCI report, cancer cases are expected to increase to 250 to 280 per lakh population by 2030. The data reveals a concerning rise in cancer cases across India, with projections indicating a significant surge in the coming years. It is imperative that we come together to address this pressing issue and work towards making cancer care more accessible and affordable for all." 

FICCI is now organising Regional Roundtables on Cancer Care under the aegis of the Ministry of Health & Family Welfare, Government of India, for further awareness as well as garnering suggestions from stakeholders across the country. Three roundtables were held in Gandhinagar, Bengaluru, and Bhubaneswar.

The FICCI Jaipur Roundtable was attended by more than 70 stakeholders from various parts of Rajasthan and neighbouring states, including government officials, senior clinicians, and representatives of hospitals, MedTech and pharma companies. It was supported by HCG Cancer Hospitals and Varian, with EY as the Knowledge Partner.